Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

No Description
UTAK LABORATORIES, INC.
ALP+ QC 2 V3 U F PT
In Commercial Distribution

  • B80003750000060 ()
  • B80003750000061 ()
  • B80003750000062 ()
  • B80003750000063 ()
  • B80003750000066 ()
  • B80003750000067 ()
  • B80003750000068 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
ALP+ QC 1 V3 U F PT
In Commercial Distribution

  • B80003750000051 ()
  • B80003750000050 ()
  • B80003750000052 ()
  • B80003750000053 ()
  • B80003750000056 ()
  • B80003750000057 ()
  • B80003750000058 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
ALP+ CAL 4 V3 U F PT
In Commercial Distribution

  • B80003750000040 ()
  • B80003750000041 ()
  • B80003750000042 ()
  • B80003750000043 ()
  • B80003750000046 ()
  • B80003750000047 ()
  • B80003750000048 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
ALP+ CAL 3 V3 U F PT
In Commercial Distribution

  • B80003750000030 ()
  • B80003750000031 ()
  • B80003750000032 ()
  • B80003750000033 ()
  • B80003750000036 ()
  • B80003750000037 ()
  • B80003750000038 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
ALP+ CAL 2 V3 U F PT
In Commercial Distribution

  • B80003750000021 ()
  • B80003750000020 ()
  • B80003750000022 ()
  • B80003750000023 ()
  • B80003750000026 ()
  • B80003750000027 ()
  • B80003750000028 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
BENZODIAZEPINES +25%
UTAK LABORATORIES, INC.
BENZO +25 PM
In Commercial Distribution

  • B80003716500091 ()
  • B80003716500090 ()
  • B80003716500092 ()
  • B80003716500093 ()
  • B80003716500096 ()
  • B80003716500097 ()
  • B80003716500098 ()


  • Benzodiazepine group IVD, control
DRUGS OF ABUSE QC LEVEL 2
UTAK LABORATORIES, INC.
DA QC 2 OF PM
In Commercial Distribution

  • B80003716500081 ()
  • B80003716500080 ()
  • B80003716500082 ()
  • B80003716500083 ()
  • B80003716500086 ()
  • B80003716500087 ()
  • B80003716500088 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
DRUGS OF ABUSE QC LEVEL 1
UTAK LABORATORIES, INC.
DA QC 1 OF PM
In Commercial Distribution

  • B80003716500071 ()
  • B80003716500070 ()
  • B80003716500072 ()
  • B80003716500073 ()
  • B80003716500076 ()
  • B80003716500077 ()
  • B80003716500078 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
BUPRENORPHINE PLUS LEVEL 2
UTAK LABORATORIES, INC.
BUP+ 2 U PM
In Commercial Distribution

  • B80003716500061 ()
  • B80003716500060 ()
  • B80003716500062 ()
  • B80003716500063 ()
  • B80003716500066 ()
  • B80003716500067 ()
  • B80003716500068 ()


  • Opiate/opiate metabolite IVD, control
BUPRENORPHINE PLUS LEVEL 1
UTAK LABORATORIES, INC.
BUP+ 1 U PM
In Commercial Distribution

  • B80003716500051 ()
  • B80003716500050 ()
  • B80003716500052 ()
  • B80003716500053 ()
  • B80003716500056 ()
  • B80003716500057 ()
  • B80003716500058 ()


  • Opiate/opiate metabolite IVD, control
FENTANYL PLUS LEVEL 1
UTAK LABORATORIES, INC.
FENT+ 1 U PM
In Commercial Distribution

  • B80003716500031 ()
  • B80003716500030 ()
  • B80003716500032 ()
  • B80003716500033 ()
  • B80003716500036 ()
  • B80003716500037 ()
  • B80003716500038 ()


  • Opiate/opiate metabolite IVD, control
No Description
UTAK LABORATORIES, INC.
430805C08
In Commercial Distribution

  • B80003716500020 ()
  • B80003716500021 ()
  • B80003716500022 ()
  • B80003716500023 ()
  • B80003716500026 ()
  • B80003716500027 ()
  • B80003716500028 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
QC 4 SMX-OF
In Commercial Distribution

  • B80002942500080 ()
  • B80002942500081 ()
  • B80002942500082 ()
  • B80002942500083 ()
  • B80002942500086 ()
  • B80002942500087 ()
  • B80002942500088 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
VIT D+ 1 S KPRICH
In Commercial Distribution

  • B80002141500020 ()
  • B80002141500021 ()
  • B80002141500022 ()
  • B80002141500023 ()
  • B80002141500026 ()
  • B80002141500027 ()
  • B80002141500028 ()


  • Multiple form 25-hydroxy Vitamin D IVD, control
DAU -25% GCMS
UTAK LABORATORIES, INC.
DAU -25 GCMS
In Commercial Distribution

  • B80000357500011 ()
  • B80000357500010 ()
  • B80000357500012 ()
  • B80000357500013 ()
  • B80000357500016 ()
  • B80000357500017 ()
  • B80000357500018 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
ALP+ CAL 1 V3 U F PT
In Commercial Distribution

  • B80003750000010 ()
  • B80003750000011 ()
  • B80003750000012 ()
  • B80003750000013 ()
  • B80003750000016 ()
  • B80003750000017 ()
  • B80003750000018 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
BENZODIAZEPINES -25%
UTAK LABORATORIES, INC.
BENZO -25 PM
In Commercial Distribution

  • B80003716500101 ()
  • B80003716500100 ()
  • B80003716500102 ()
  • B80003716500103 ()
  • B80003716500106 ()
  • B80003716500107 ()
  • B80003716500108 ()

  • Total Volume: 10 Milliliter
BENZO -25 PM

  • Benzodiazepine group IVD, control
FENTANYL PLUS LEVEL 2
UTAK LABORATORIES, INC.
FENT+ 2 U PM
In Commercial Distribution

  • B80003716500041 ()
  • B80003716500040 ()
  • B80003716500042 ()
  • B80003716500043 ()
  • B80003716500046 ()
  • B80003716500047 ()
  • B80003716500048 ()


  • Opiate/opiate metabolite IVD, control
No Description
UTAK LABORATORIES, INC.
430806C08
In Commercial Distribution

  • B80003716500010 ()
  • B80003716500011 ()
  • B80003716500012 ()
  • B80003716500013 ()
  • B80003716500016 ()
  • B80003716500017 ()
  • B80003716500018 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
P/Z QC V2 L U F ML
In Commercial Distribution

  • B80002942500101 ()
  • B80002942500100 ()
  • B80002942500102 ()
  • B80002942500103 ()
  • B80002942500106 ()
  • B80002942500107 ()
  • B80002942500108 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
QC 3 SMX-OF
In Commercial Distribution

  • B80002942500091 ()
  • B80002942500090 ()
  • B80002942500092 ()
  • B80002942500093 ()
  • B80002942500096 ()
  • B80002942500097 ()
  • B80002942500098 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
DOA CAL P OF V6
In Commercial Distribution

  • B80002942500071 ()
  • B80002942500070 ()
  • B80002942500072 ()
  • B80002942500073 ()
  • B80002942500076 ()
  • B80002942500077 ()
  • B80002942500078 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
P/Z QC H U F ML
In Commercial Distribution

  • B80002942500060 ()
  • B80002942500061 ()
  • B80002942500062 ()
  • B80002942500063 ()
  • B80002942500066 ()
  • B80002942500067 ()
  • B80002942500068 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
P/Z QC LOW
In Commercial Distribution

  • B80002942500051 ()
  • B80002942500050 ()
  • B80002942500052 ()
  • B80002942500053 ()
  • B80002942500056 ()
  • B80002942500057 ()
  • B80002942500058 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
P/Z CAL V2 U F ML
In Commercial Distribution

  • B80002942500041 ()
  • B80002942500040 ()
  • B80002942500042 ()
  • B80002942500043 ()
  • B80002942500046 ()
  • B80002942500047 ()
  • B80002942500048 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
PSY UR V3 CAL
In Commercial Distribution

  • B80002942500030 ()
  • B80002942500031 ()
  • B80002942500032 ()
  • B80002942500033 ()
  • B80002942500036 ()
  • B80002942500037 ()
  • B80002942500038 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
P/Z CAL U F ML
In Commercial Distribution

  • B80002942500020 ()
  • B80002942500021 ()
  • B80002942500022 ()
  • B80002942500023 ()
  • B80002942500026 ()
  • B80002942500027 ()
  • B80002942500028 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
PM PAN COM V9
In Commercial Distribution

  • B80002942500010 ()
  • B80002942500011 ()
  • B80002942500012 ()
  • B80002942500013 ()
  • B80002942500016 ()
  • B80002942500017 ()
  • B80002942500018 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
No Description
UTAK LABORATORIES, INC.
VIT D+ 2 S KPRICH
In Commercial Distribution

  • B80002141500030 ()
  • B80002141500031 ()
  • B80002141500032 ()
  • B80002141500033 ()
  • B80002141500036 ()
  • B80002141500037 ()
  • B80002141500038 ()


  • Multiple form 25-hydroxy Vitamin D IVD, control
No Description
UTAK LABORATORIES, INC.
VIT D+ L S KPRICH
In Commercial Distribution

  • B80002141500010 ()
  • B80002141500011 ()
  • B80002141500012 ()
  • B80002141500013 ()
  • B80002141500016 ()
  • B80002141500017 ()
  • B80002141500018 ()


  • Multiple form 25-hydroxy Vitamin D IVD, control
DRUGS OF ABUSE LEVEL 3
UTAK LABORATORIES, INC.
DA 3 S IDC
In Commercial Distribution

  • B80002041000031 ()
  • B80002041000030 ()
  • B80002041000032 ()
  • B80002041000033 ()
  • B80002041000036 ()
  • B80002041000037 ()
  • B80002041000038 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
DRUGS OF ABUSE LEVEL 2
UTAK LABORATORIES, INC.
DA 2 S IDC
In Commercial Distribution

  • B80002041000021 ()
  • B80002041000020 ()
  • B80002041000022 ()
  • B80002041000023 ()
  • B80002041000026 ()
  • B80002041000027 ()
  • B80002041000028 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
DRUGS OF ABUSE LEVEL 1
UTAK LABORATORIES, INC.
DA 1 S IDC
In Commercial Distribution

  • B80002041000011 ()
  • B80002041000010 ()
  • B80002041000012 ()
  • B80002041000013 ()
  • B80002041000016 ()
  • B80002041000017 ()
  • B80002041000018 ()


  • Multiple therapeutic drugs/drugs of abuse IVD, control
GHB 20 MG/L
UTAK LABORATORIES, INC.
GHB 20 U IN
In Commercial Distribution

  • B80001978000021 ()
  • B80001978000020 ()
  • B80001978000022 ()
  • B80001978000023 ()
  • B80001978000026 ()
  • B80001978000027 ()
  • B80001978000028 ()


  • Gamma-hydroxybutyrate (GHB) IVD, control
BUSULFAN LEVEL 3
UTAK LABORATORIES, INC.
BUS 3 P F UK
In Commercial Distribution

  • B80001696000091 ()
  • B80001696000090 ()
  • B80001696000092 ()
  • B80001696000093 ()
  • B80001696000096 ()
  • B80001696000097 ()
  • B80001696000098 ()


  • Busulfan therapeutic drug monitoring IVD, control
BUSULFAN LEVEL 2
UTAK LABORATORIES, INC.
BUS 2 P F UK
In Commercial Distribution

  • B80001696000081 ()
  • B80001696000080 ()
  • B80001696000082 ()
  • B80001696000083 ()
  • B80001696000086 ()
  • B80001696000087 ()
  • B80001696000088 ()


  • Busulfan therapeutic drug monitoring IVD, control
BUSULFAN LEVEL 1
UTAK LABORATORIES, INC.
BUS 1 P F UK
In Commercial Distribution

  • B80001696000071 ()
  • B80001696000070 ()
  • B80001696000072 ()
  • B80001696000073 ()
  • B80001696000076 ()
  • B80001696000077 ()
  • B80001696000078 ()


  • Busulfan therapeutic drug monitoring IVD, control
METALS LEVEL 2
UTAK LABORATORIES, INC.
MET T 2 DP UK
In Commercial Distribution

  • B80001696000041 ()
  • B80001696000040 ()
  • B80001696000042 ()
  • B80001696000043 ()
  • B80001696000046 ()
  • B80001696000047 ()
  • B80001696000048 ()


  • Multiple heavy metal IVD, control
METALS LEVEL 1
UTAK LABORATORIES, INC.
MET T 1 DP UK
In Commercial Distribution

  • B80001696000031 ()
  • B80001696000030 ()
  • B80001696000032 ()
  • B80001696000033 ()
  • B80001696000036 ()
  • B80001696000037 ()
  • B80001696000038 ()


  • Multiple heavy metal IVD, control
METALS LEVEL 2
UTAK LABORATORIES, INC.
MET T 2 WB UK
In Commercial Distribution

  • B80001696000021 ()
  • B80001696000020 ()
  • B80001696000022 ()
  • B80001696000023 ()
  • B80001696000026 ()
  • B80001696000027 ()
  • B80001696000028 ()


  • Multiple heavy metal IVD, control
< 1 2 3 4 5 ... 250 >